Top 5 Companies Likely to Transact (Apr 17, 2026)

Top 5 Companies Likely to Transact (Apr 17, 2026)

Top 5 Companies Likely to Transact (Apr 17, 2026)
7:50

Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.

Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.

Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.

Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.

Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.

Sourced from Dakota Sponsor Backed Companies.

1. Alphabiome

Alphabiome is a Tel Aviv-based biotechnology company founded in March 2022 that uses AI to decode the genetic complexity of the human microbiome, turning trillions of microbial DNA fragments into actionable insights for drug development and precision medicine. Co-founded by Alex Pentland and Yaniv Altshuler, the company recently validated its AI model in a controlled livestock trial assessing the methane-reducing effect of a nutritional additive.

  • Sector: Health Care
  • Last known transaction date: Seed Venture, $8M, May 2025
  • Why timing suggests a near-term transaction: Alphabiome closed an $8M Seed round in May 2025, and at roughly 11 months post-raise, microbiome and precision health ventures at this funding level typically deploy capital toward platform development, early clinical data generation, and scientific talent acquisition, resource-intensive activities that compress runway within the 18–24 month window. This positions Alphabiome in the active pre-Series A window where foundational proof-of-concept data and pipeline validation are likely coming into focus ahead of a likely raise in the next 6–12 months.

View all private company data in Dakota Marketplace.

2. IXI Eyewear Oy

IXI Eyewear Oy is a Finland-based technology company founded in 2021 that develops adaptive eyewear with dynamic lenses that adjust focus based on eye movement. The company is focused on advancing vision correction through intelligent, auto-adjusting glasses currently in development.

  • Sector: Health Care
  • Last known transaction date: Venture Series A, $36.5M, April 2025
  • Why timing suggests a near-term transaction: IXI Eyewear Oy’s $36.5M Series A announced in April 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A consumer hardware and wearable technology companies preparing for their next growth round. As product commercialization, retail distribution, and brand adoption expand, the company is likely to evaluate follow-on capital, strategic partnerships, or acquisition interest.

View all private company data in Dakota Marketplace.

3. Nuvia

Nuvia is a Brazilian AI-driven sales automation platform that deploys autonomous agents to manage lead generation, prospecting, and customer engagement for B2B teams. Its platform streamlines sales workflows and delivers data-driven insights to improve conversion and revenue efficiency.

  • Sector: B2B SaaS / AI Automation
  • Last known funding round: Seed, $1.7M, April 2025
  • Why timing suggests a near-term transaction: Nuvia’s $1.7M seed round announced in April 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026, aligning with the typical window when seed-stage companies begin preparing for their next raise. As product development, early customer traction, and market validation progress, the company is likely to evaluate follow-on capital, strategic partnerships, or early acquisition interest.

View all private company data in Dakota Marketplace.

4. Doubleword

Doubleword is a London-based company specializing in self-hosted AI inference platforms. Founded in 2021 by Dr. Jamie Dborin, Dr. Fergus Finn, and Meryem Arik, the company enables enterprises to deploy, manage, and scale AI models across various infrastructures, including on-premise and cloud environments, without vendor lock-in. Their platform supports a wide range of AI applications, from chatbots to complex models like cancer detection, allowing organizations to integrate AI seamlessly into their operations.

  • Sector: AI Infrastructure / Enterprise Software
  • Last known funding round: Venture, ~$12M, May 2025
  • Why timing suggests a near-term transaction: Doubleword’s ~$12M funding round in May 2025 positions the company within the typical 12–18 month window for a follow-on raise. As demand for enterprise-controlled AI infrastructure grows, particularly around data privacy, cost optimization, and vendor independence, the company is likely to pursue additional capital to scale its platform, expand enterprise adoption, and strengthen its position in the rapidly evolving AI infrastructure market.

View all private company data in Dakota Marketplace.

5. InventWood

InventWood is a Maryland-based materials science company founded in 2016 that develops engineered wood products for construction applications. Its Superwood material is designed to enhance strength, durability, and performance compared to traditional wood.

  • Sector: Materials
  • Last known funding round: Series A Venture, $15M, April 2025
  • Why timing suggests a near-term transaction: InventWood’s $15M Series A announced in April 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A advanced materials companies preparing for their next growth round. As production capabilities, commercial partnerships, and demand for sustainable building materials expand, the company is likely to evaluate follow-on capital, strategic industrial investment, or acquisition interest.

View all private company data in Dakota Marketplace.

Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does

Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.

Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.

Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.

To explore more companies likely to transact, book a demo of Dakota Marketplace!

Morgan Holycross, Marketing Manager

Written By: Morgan Holycross, Marketing Manager

Morgan Holycross is a Marketing Manager at Dakota.